InvestSMART

Nuchev Limited (ASX:NUC)

ALERT: Price-sensitive ASX Announcement for NUC
Current share price for NUC : $0.085 -0.055 (-39.29%)+
Announcement
Release
27 Apr 2026 1:04PM
Price at Release
$0.140
Full Release
download
Summary
Nuchev Limited, an Australian-based nutritional and wellness business, released its Appendix 4C and Quarterly Activities Report for Q3 FY26. The company reported a Group sales revenue of $4.7 million, a decrease of 11% compared to the previous quarter and 12% compared to the same period last year, bringing the year-to-date sales to $16.5 million. The report highlights mixed trading conditions, with resilient performance in the ANZ retail sector, while international revenue conversion was affected by timing issues. The Practitioner channel showed some stabilization despite a softer performance. The company is focused on disciplined execution and working capital management to support its growth and move toward profitability. Cash at the end of the quarter was $2.1 million, and the company has been managing its working capital requirements through an unsecured working capital facility.
Key Points
  • Group sales revenue for Q3 FY26 was $4.7 million, down 11% quarter-on-quarter and 12% year-on-year.
  • Year-to-date Group sales revenue reached $16.5 million at 31 March 2026.
  • ANZ retail sector remained resilient; international revenue conversion affected by timing.
  • Practitioner channel sales revenue was $1.5 million, with some stabilization toward the quarter end.
  • Net cash used in operating activities for the quarter was $2.9 million.
  • Cash at 31 March 2026 was $2.1 million.
  • Nuchev continues to focus on disciplined execution, working capital management, and profitability.
  • The company transitioned to a $2.0 million unsecured working capital facility during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.